市場調查報告書
商品編碼
1625225
到 2030 年內視鏡手術設備市場預測:按產品類型、使用類型、應用、最終用戶和地區進行的全球分析Endoscopy Operative Devices Market Forecasts to 2030 - Global Analysis By Product Type (Energy Systems, Access Devices, Suction & Irrigation Systems and Other Product Types), Usage Type (Reusable and Disposable), Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球內視鏡手術設備市場規模將達109億美元,預計2030年將達到155億美元,預測期內複合年成長率為6.1%。
內視鏡手術設備是指內視鏡手術過程中診斷、治療和監測器官和腔道狀況的專用工具。這些器械包括鑷子、剪刀、勒除器、抓緊器和基於力的器械,穿透力較低。這些器械應用於胃腸外科、風濕科、婦科等領域,以提高手術效率、縮短病患復原時間、降低手術風險。其先進的人體工學設計和功能滿足特定的醫療需求,並使其適合現代內科實踐。
內視鏡設備持續創新
內視鏡設備的持續技術創新是市場的關鍵驅動力,製造商專注於整合先進技術以提高影像品質和設備可操作性。這些創新使微創手術成為可能,具有更快的恢復時間和降低併發症風險等優點。透過投資研發,公司正在引入新的功能,以滿足醫療保健專業人員和患者不斷變化的需求,從而改善患者的治療效果並擴大不同醫療專業的市場範圍。
中樞神經系統和感染疾病風險
與內視鏡手術相關的感染疾病風險是市場的主要限制。由於膽道引流不完全和器械污染等因素,ERCP 等手術可能會導致感染疾病。這種風險需要採取嚴格的感染控制措施,並可能增加醫療保健提供者的營運成本和複雜性。此外,由於擔心感染風險,一些患者不願接受內視鏡手術,儘管設備技術取得了進步,但這可能會限制市場成長。
對微創的需求不斷增加
對微創手術不斷成長的需求為內視鏡手術設備市場帶來了巨大的機會。微創手術有很多好處,包括術後疼痛更少、恢復更快、住院時間更短。隨著患者和醫療保健提供者對這些好處的認知不斷增強,對內視鏡解決方案的需求也不斷增加。提高手術效率和患者治療效果的技術進步進一步推動了這一趨勢,推動了市場擴張。
嚴格的監管核准
嚴格的監管核准對內視鏡手術設備市場構成威脅。 FDA 等監管機構實施嚴格的安全和品質標準,可能會減緩產品開發和市場滲透。遵守這些法規需要大量時間和資源,這可能會阻礙創新並增加製造商的成本。這些挑戰可能會限制新產品的推出並減緩市場成長,特別是對於不具備廣泛監管專業知識的中小企業而言。
COVID-19 大流行最初擾亂了內視鏡手術設備市場,因為它推遲了擇期手術並將資源轉移到管理 COVID-19 病例上。結果,需求暫時減少。然而,隨著醫療保健系統的適應,由於治療的重新安排和旨在提高效率和感染控制的設備技術創新,內視鏡手術的需求有所反彈。
可重複使用手術器械細分市場預計將在預測期內成為最大的細分市場
由於其成本效益和耐用性,可重複使用的手術器械預計將在預測期內佔據最大的市場佔有率。這些儀器受到醫療保健提供者的青睞,因為它們可以承受多次滅菌,同時保持性能。對微創手術不斷成長的需求進一步增強了該領域的主導地位。因為可重複使用的器械可以提高複雜手術期間的可視化和可操作性。
胃腸外科領域預計在預測期內複合年成長率最高
胃腸外科領域預計在預測期內複合年成長率最高。這一成長背後的驅動力是全球胃腸道疾病的盛行率不斷上升。內視鏡工具的技術進步提高了診斷準確性和治療效果,使這些手術更具吸引力。隨著新興市場醫療保健基礎設施的改善,胃腸內視鏡檢查的採用預計將大幅增加。
由於其先進的醫療基礎設施和需要內視鏡干預的慢性疾病的高盛行率,預計北美地區在預測期內將佔據最大的市場佔有率。投資創新解決方案的領先市場參與者的存在進一步鞏固了北美的地位。優惠的報銷政策也支持先進內視鏡技術的擴散。
由於先進技術的日益採用和老年人口的增加,預計亞太地區在預測期內將實現最高的成長率。對微創手術的認知不斷提高以及醫療保健基礎設施的改善促進了這一成長。隨著對有效診斷和治療解決方案的需求增加,亞太地區正在成為全球市場的關鍵成長地區。
According to Stratistics MRC, the Global Endoscopy Operative Devices Market is accounted for $10.9 billion in 2024 and is expected to reach $15.5 billion by 2030 growing at a CAGR of 6.1% during the forecast period. Endoscopic surgical devices are specialized tools for diagnosing, treating, or monitoring conditions in organs and cavities during endoscopic surgery. These devices include forceps, scissors, snares, graspers, and force-based devices, which are less penetrating. Techniques are designed to perform specific surgical tasks when used in areas such as gastroenterology, rheumatology, and gynecology; they improve surgical efficiency, reduce patient recovery time, and reduce surgical risks. Their advanced ergonomic design and function meet specific medical needs, making them relevant in modern internal medicine practice.
Continuous innovation in endoscopy devices
Continuous innovation in endoscopy devices is a key driver for the market, as manufacturers focus on integrating advanced technologies to enhance imaging quality and device maneuverability. These innovations enable minimally invasive procedures, which offer benefits such as reduced recovery times and lower risks of complications. By investing in research and development, companies introduce new capabilities that meet the evolving needs of healthcare providers and patients, thereby improving patient outcomes and expanding the market's reach across various medical specialties.
Risk of CNS and infections
The risk of infections associated with endoscopic procedures is a significant restraint on the market. Procedures like ERCP can lead to infections due to factors such as incomplete biliary drainage and contaminated equipment. This risk necessitates stringent infection control measures, which can increase operational costs and complexity for healthcare providers. Concerns about infection risks may also deter some patients from undergoing endoscopic procedures, potentially limiting market growth despite advancements in device technology.
Rising demand for minimally invasive
The rising demand for minimally invasive procedures presents a significant opportunity for the endoscopy operative devices market. These procedures offer numerous advantages, including less postoperative pain, quicker recovery, and reduced hospital stays. As awareness of these benefits grows among patients and healthcare providers, the demand for endoscopic solutions increases. This trend is further supported by technological advancements that enhance procedural efficiency and patient outcomes, driving market expansion.
Stringent regulatory approvals
Stringent regulatory approvals pose a threat to the endoscopy operative devices market. Regulatory bodies like the FDA impose rigorous safety and quality standards that can delay product development and market entry. Compliance with these regulations requires significant time and resources, potentially hindering innovation and increasing costs for manufacturers. These challenges can limit the introduction of new products and slow market growth, particularly for smaller companies lacking extensive regulatory expertise.
The COVID-19 pandemic initially disrupted the endoscopy operative devices market due to postponed elective procedures and resource diversion towards managing COVID-19 cases. This led to a temporary decline in demand. However, as healthcare systems adapted, there was a rebound in demand for endoscopic procedures, driven by rescheduled treatments and innovations in device technology aimed at improving efficiency and infection control.
The reusable operative devices segment is expected to be the largest during the forecast period
The reusable operative devices segment is expected to account for the largest market share during the forecast period due to their cost-effectiveness and durability. These devices are favored by healthcare providers for their ability to withstand multiple sterilizations while maintaining performance. The growing demand for minimally invasive surgeries further drives this segment's dominance, as reusable devices offer enhanced visualization and maneuverability during complex procedures.
The gastrointestinal surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gastrointestinal surgery segment is expected to witness the highest CAGR. This growth is driven by the increasing prevalence of gastrointestinal disorders globally. Technological advancements in endoscopic tools enhance diagnostic accuracy and therapeutic outcomes, making these procedures more appealing. As healthcare infrastructure improves in emerging markets, the adoption of gastrointestinal endoscopy is expected to rise significantly.
The North America region is anticipated to account for the largest market share during the forecast period due to its advanced healthcare infrastructure and high prevalence of chronic diseases requiring endoscopic intervention. The presence of key market players investing in innovative solutions further strengthens North America's position. Favorable reimbursement policies also support widespread adoption of advanced endoscopic technologies.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to increasing adoption of advanced technologies and a growing geriatric population. Rising awareness about minimally invasive procedures and improvements in healthcare infrastructure contribute to this growth. As demand for effective diagnostic and therapeutic solutions increases, Asia Pacific emerges as a key growth region in the global market landscape.
Key players in the market
Some of the key players in Endoscopy Operative Devices Market include Olympus Corporation, Boston Scientific Corporation, Stryker Corporation, KARL STORZ GmbH & Co. KG, FUJIFILM Holdings Corporation, Smith & Nephew PLC, Ethicon Endo-Surgery, B. Braun Melsungen AG, Cook Medical, Inc., Intuitive Surgical, Inc., Medtronic PLC, Hoya Corporation, Richard Wolf GmbH, Arthrex, Inc., ConMed Corporation, Ambu A/S, Cantel Medical and Hillrom.
In October 2024, Olympus announces CE approval for three cloud-based AI medical devices, enhancing clinical outcomes and operational efficiency in endoscopy, with plans for an AI-powered endoscopy ecosystem in 2025.
In October 2023, B. Braun launches its newest laparoscopic AESCULAP(R) EinsteinVision(R) 3.0 FI during International Society for Gynecologic Endoscopy (ISGE) Annual Meeting 2023 at Sanur, Bali. This latest version is equipped with 3D Fluorescence Imaging that enables imaging in real time through its three different FI overlay modes.
In February 2023, KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company, enhancing its ENT portfolio with a breakthrough single-use medical device for tympanostomy procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.